Answers are grounded in this paper and cite their sources.
Viewpoint discusses blood-based biomarkers for Alzheimer disease and communication strategies for assisted dying.
This Viewpoint discusses the expansion of blood-based biomarker testing for Alzheimer disease and outlines patient-physician communication strategies for end-of-life questions and physician-assisted death.
No takes yet. Share an insight, caveat, or question.
Lyndon et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: